Accessibility Menu
Strata Critical Medical logo

Strata Critical Medical(NASDAQ) SRTA

Current Price$5.08
Market Cap$446.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-47%
5 Year-36%
1 Year+12%
1 Month-12%
Strata Critical Medical last closing stock price
MetricPriceDate
Last closeUSD 5.162026-07-21
Strata Critical Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.27%USD 5.282026-07-14
1 month-12.24%USD 5.882026-06-18
3 month+3.2%USD 5.002026-04-22
Year to date+7.28%USD 4.812025-12-31
1 year+12.42%USD 4.592025-07-21
3 year+31.97%USD 3.912023-07-21
5 year-35.66%USD 8.022021-07-22
Since inception-47.08%USD 9.752019-11-05

Strata Critical Medical Financials at a Glance

Market Cap

$446.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$254.27M

Net Income (TTM)

$46.99M

EPS (TTM)

-$0.12

P/E Ratio

-44.03

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$5.08

Volume

616,222.537

Open

$5.13

Previous Close

$5.08

Daily Range

$5.05 - $5.21

52-Week Range

$3.68 - $6.50

Estimated Earnings Date

Aug 4, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Strata Critical Medical

Strata helps hospitals move human organs quickly for life-saving surgeries. It uses planes and cars to move medical teams and organs. Strata also provides staff and equipment for organ recovery and heart operations.

What Strata Does

  • Logistics: Air and ground transport for organs and surgical teams under the Trinity brand; accounts for 71% of revenue.
  • Clinical Services: Surgical organ recovery and heart surgery support provided by the Keystone brand; makes up 29% of revenue.
  • Organ Placement: Administrative support that helps doctors decide if a donor organ is right for a patient.

Big Moves and Mergers

  • Sold the passenger transportation business to Joby Aero, Inc. in August 2025 to focus exclusively on healthcare.
  • Acquired Keystone Perfusion Services, LLC in September 2025 to add surgical recovery and clinical staffing capabilities.
  • Purchased the assets of Ohio Valley Perfusion Associates, Inc. in April 2026 to grow heart surgery support services.
  • Secured a $30 million credit facility from JPMorgan Chase Bank, N.A. in January 2026 for working capital.

Why the Model Works

Strata uses an asset-light model by primarily hiring third-party planes while owning a small fleet for high-volume areas. This integrated solution combines transport with surgical staff to help hospitals save time and money during transplants.

Checking the Vital Signs

  • Revenue reached $67.4 million in Q1 2026, up 87% from $35.9 million in Q1 2025.
  • Net income turned positive at $2.2 million in Q1 2026, improving from a $3.5 million loss in Q1 2025.
  • Gross profit hit $14.1 million for the quarter ended March 31, 2026, up 100% year-over-year.
  • Operating loss narrowed to $3 million in Q1 2026, representing a 48% improvement from the prior year period.

Bottom Line

Strata has transformed from a general flight provider into a specialized healthcare logistics and clinical services company. Its focus on the transplant market and recent acquisitions have significantly increased revenue and led to positive net income.

AI Generated • May 7, 2026

Industry

Healthcare Providers and Services

Employees

601

CEO

William A. Heyburn; Melissa M. Tomkiel

Headquarters

New York, NY 10001, US

SRTA Financials

Key Financial Metrics (TTM)

Gross Margin

21.68%

Operating Margin

-7.85%

Net Income Margin

18.48%

Return on Equity

17.55%

Return on Capital

-7.92%

Return on Assets

14.34%

Earnings Yield

-2.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$446.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

86.53M

Volume

616.22K

Avg. Volume

1.12M

Financials (TTM)

Gross Profit

$55.14M

Operating Income

-$19.96M

EBITDA

-$9.30M

Operating Cash Flow

-$39.66M

Capital Expenditure

-$13.35M

Free Cash Flow

-$53.00M

Cash & ST Invst.

$58.79M

Total Debt

$4.47M

Strata Critical Medical Performance Analysis

Strata Critical Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 146,120,000189.2%
20232023-12-31USD 225,180,00054.1%
20242024-12-31USD 146,817,000-34.8%
20252025-12-31USD 197,141,00034.3%
Strata Critical Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3030.4%
Q32025-09-30-30.4%
Q42025-12-3135.5%
Q12026-03-310.9%
Strata Critical Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.38-59.0%
20232023-12-31USD -0.7699.3%
20242024-12-31USD -0.35-53.8%
20252025-12-31USD -0.19-45.9%
Strata Critical Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-15.0%
Q32025-09-3020.4%
Q42025-12-31-200.5%
Q12026-03-31125.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$67.38M

+24.1%

Gross Profit

$14.12M

+17.9%

Gross Margin

20.95%

N/A

Market Cap

$446.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$742.89K

N/A

Employees

601

N/A

Net Income

$2.15M

+161.7%

EBITDA

$1.16M

+163.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$58.79M

-51.0%

Total Debt

$4.47M

-50.7%

Accounts Receivable

$39.60M

+79.0%

Inventory

$0.00

N/A

Long Term Debt

$3.48M

-39.0%

Short Term Debt

$987.00K

-70.6%

Return on Assets

14.34%

N/A

Return on Invested Capital

-6.51%

N/A

Free Cash Flow

-$1.93M

+43.2%

Operating Cash Flow

$3.56M

+1545.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ULHUniversal Logistics Holdings, Inc.
$16.06+3.88%
ORNOrion Group Holdings, Inc.
$13.15-1.79%
EBFEnnis, Inc.
$21.28+0.14%
MTRXMatrix Service Company
$12.53+0.16%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$23.04+0.04%
SMCISuper Micro Computer
$30.56+0.20%
AALAmerican Airlines Group
$14.79-0.03%
NOKNokia
$10.28-0.03%

Questions About SRTA

What is the current price of Strata Critical Medical?

Strata Critical Medical is trading at $5.08 per share.

What is the 52-week range for Strata Critical Medical?

Over the past 52 weeks, Strata Critical Medical has traded between $3.68 and $6.50.

How much debt does Strata Critical Medical have?

As of the most recent reporting period, Strata Critical Medical reported total debt of $4.47M.

How much cash does Strata Critical Medical have on hand?

Strata Critical Medical reported $58.99M in cash and cash equivalents in its most recent financial results.

What is Strata Critical Medical’s dividend yield?

Strata Critical Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.